Falcarindiol

CAS No. 225110-25-8

Falcarindiol ( (3R,8S)-Falcarindiol; 3(R),8(S),9(Z)-Falcarindiol )

Catalog No. M18262 CAS No. 225110-25-8

Falcarindiol is a potential new anticancer agent that exerts its activity through inducing ER stress and apoptosis.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 140 In Stock
10MG 222 In Stock
25MG 376 In Stock
50MG 536 In Stock
100MG 777 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Falcarindiol
  • Note
    Research use only, not for human use.
  • Brief Description
    Falcarindiol is a potential new anticancer agent that exerts its activity through inducing ER stress and apoptosis.
  • Description
    Falcarindiol is a potential new anticancer agent that exerts its activity through inducing ER stress and apoptosis. Falcarindiol induces immunosuppressive effects in vitro and in vivo and might be a novel therapy for autoimmune or allergic diseases. Falcarindiol has protective effect against CCl(4) toxicity , in part, be explained by anti-lipid peroxidation activity associated with the induction of the GSTs including GSTA4.
  • Synonyms
    (3R,8S)-Falcarindiol; 3(R),8(S),9(Z)-Falcarindiol
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    225110-25-8
  • Formula Weight
    260.37
  • Molecular Formula
    C17H24O2
  • Purity
    98%
  • Solubility
    ——
  • SMILES
    CCCCCCCC=CC(C#CC#CC(C=C)O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Sivifene

    Sivifene can be used for research on the treatment of cutaneous metastases from cancer.

  • Murepavadin TFA

    Murepavadin (TFA) is a 14-amino acid cyclic peptide that is a potent, specific antibiotic used to treat bacterial infections caused by Pseudomonas aeruginosa.Murepavadin (TFA) targets the LPS transporter portin D.

  • Visnagin

    Visnagin has acute hypotensive anti-inflammatory and neuroprotective effects it protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenase.